5ht2c receptor modulator compositions and methods of use

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01) A61K 31/55 (2006.01) A61P 3/04 (2006.01)

Patent

CA 2588941

The present invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist. In addition, the invention relates to a composition comprising phentermine and a selective 5HT-2C receptor agonist having Formula (I): or a pharmaceutically acceptable salt, solvate or hydrate thereof. These compositions are useful in pharmaceutical compositions whose use includes the treatment of obesity.

La présente invention concerne une composition renfermant de la phentermine et un agoniste sélectif des récepteurs 5HT-2C. Cette invention concerne en outre une composition renfermant de la phentermine et un agoniste sélectif des récepteurs 5HT-2C représenté par la formule (I) ou un sel, un solvate ou un hydrate pharmaceutiquement acceptable de celui-ci. Ces compositions sont utilisées dans des compositions pharmaceutiques servant notamment au traitement de l'obésité.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

5ht2c receptor modulator compositions and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5ht2c receptor modulator compositions and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5ht2c receptor modulator compositions and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1710845

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.